| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8794911 | Ophthalmology Retina | 2017 | 10 Pages |
Abstract
No safety issue was noted associated with combining 16 GyE or 24 GyE PBT with intravitreal anti-VEGF therapy in eyes with exudative age-related macular degeneration. Overall improvements in BCVA and imaging parameters were not affected by the addition of PBT, but the number of anti-VEGF treatments needed was significantly lower with the addition of 24 GyE PBT.
Keywords
CNVMSRFPBTRPESpectral-Domain OCTPEDSD-OCTBCVAlogMARgeographic atrophyfluorescein angiographyretinal pigment epitheliumbest-corrected visual acuityProton beam therapyexudative age-related macular degenerationchoroidal neovascular membraneVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)logarithm of the minimum angle of resolutionSubretinal fluidsubretinal hyperreflective material
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Senad MD, Elad MD, Kavita K. MD, MPH, Inder PhD, Ala MD, PhD, Lawrence MD, PhD, Susanna S. MD, PhD,